Your browser doesn't support javascript.
loading
Patterns, predictors, and patient-reported reasons for antidepressant discontinuation in the WHO World Mental Health Surveys.
Kazdin, Alan E; Harris, Meredith G; Hwang, Irving; Sampson, Nancy A; Stein, Dan J; Viana, Maria Carmen; Vigo, Daniel V; Wu, Chi-Shin; Aguilar-Gaxiola, Sergio; Alonso, Jordi; Benjet, Corina; Bruffaerts, Ronny; Caldas-Almeida, José Miguel; Cardoso, Graça; Caselani, Elisa; Chardoul, Stephanie; Cía, Alfredo; de Jonge, Peter; Gureje, Oye; Haro, Josep Maria; Karam, Elie G; Kovess-Masfety, Viviane; Navarro-Mateu, Fernando; Piazza, Marina; Posada-Villa, José; Scott, Kate M; Stagnaro, Juan Carlos; Ten Have, Margreet; Torres, Yolanda; Vladescu, Cristian; Kessler, Ronald C.
Afiliação
  • Kazdin AE; Department of Psychology, Yale University, New Haven, CT, USA.
  • Harris MG; School of Public Health, The University of Queensland, Herston, QLD 4006, Australia.
  • Hwang I; Queensland Centre for Mental Health Research, The Park Centre for Mental Health, QLD 4072, Australia.
  • Sampson NA; Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
  • Stein DJ; Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
  • Viana MC; Department of Psychiatry & Mental Health and South African Medical Council Research Unit on Risk and Resilience in Mental Disorders, University of Cape Town, Cape Town, South Africa.
  • Vigo DV; Groote Schuur Hospital, Cape Town, South Africa.
  • Wu CS; Department of Social Medicine, Postgraduate Program in Public Health, Federal University of Espírito Santo, Vitoria, Brazil.
  • Aguilar-Gaxiola S; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
  • Alonso J; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
  • Benjet C; National Center for Geriatrics and Welfare Research, National Health Research Institutes, Zhunan Town, Taiwan.
  • Bruffaerts R; Center for Reducing Health Disparities, UC Davis Health System, Sacramento, CA, USA.
  • Caldas-Almeida JM; Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain.
  • Cardoso G; Department of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.
  • Caselani E; CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • Chardoul S; National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.
  • Cía A; Universitair Psychiatrisch Centrum - Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium.
  • de Jonge P; Lisbon Institute of Global Mental Health and Comprehensive Health Research Centre, NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal.
  • Gureje O; Lisbon Institute of Global Mental Health and Comprehensive Health Research Centre, NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal.
  • Haro JM; Unit of Epidemiological and Evaluation Psychiatry, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
  • Karam EG; Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA.
  • Kovess-Masfety V; Anxiety Disorders Research Center, Buenos Aires, Argentina.
  • Navarro-Mateu F; Department of Developmental Psychology, University of Groningen, Groningen, The Netherlands.
  • Piazza M; Interdisciplinary Center Psychopathology and Emotion Regulation, University Medical Center Groningen, Groningen, The Netherlands.
  • Posada-Villa J; Department of Psychiatry, University College Hospital, Ibadan, Nigeria.
  • Scott KM; Research, Teaching and Innovation Unit, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain.
  • Stagnaro JC; Centre for Biomedical Research on Mental Health (CIBERSAM), Madrid, Spain.
  • Ten Have M; Departament de Medicine, Universitat de Barcelona, Barcelona, Spain.
  • Torres Y; Department of Psychiatry and Clinical Psychology, Faculty of Medicine, Balamand University, Beirut, Lebanon.
  • Vladescu C; Department of Psychiatry and Clinical Psychology, St George Hospital University Medical Center, Beirut, Lebanon.
  • Kessler RC; Institute for Development Research Advocacy and Applied Care (IDRAAC), Beirut, Lebanon.
Psychol Med ; 54(1): 67-78, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37706298
ABSTRACT

BACKGROUND:

Despite their documented efficacy, substantial proportions of patients discontinue antidepressant medication (ADM) without a doctor's recommendation. The current report integrates data on patient-reported reasons into an investigation of patterns and predictors of ADM discontinuation.

METHODS:

Face-to-face interviews with community samples from 13 countries (n = 30 697) in the World Mental Health (WMH) Surveys included n = 1890 respondents who used ADMs within the past 12 months.

RESULTS:

10.9% of 12-month ADM users reported discontinuation-based on recommendation of the prescriber while 15.7% discontinued in the absence of prescriber recommendation. The main patient-reported reason for discontinuation was feeling better (46.6%), which was reported by a higher proportion of patients who discontinued within the first 2 weeks of treatment than later. Perceived ineffectiveness (18.5%), predisposing factors (e.g. fear of dependence) (20.0%), and enabling factors (e.g. inability to afford treatment cost) (5.0%) were much less commonly reported reasons. Discontinuation in the absence of prescriber recommendation was associated with low country income level, being employed, and having above average personal income. Age, prior history of psychotropic medication use, and being prescribed treatment from a psychiatrist rather than from a general medical practitioner, in comparison, were associated with a lower probability of this type of discontinuation. However, these predictors varied substantially depending on patient-reported reasons for discontinuation.

CONCLUSION:

Dropping out early is not necessarily negative with almost half of individuals noting they felt better. The study underscores the diverse reasons given for dropping out and the need to evaluate how and whether dropping out influences short- or long-term functioning.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medidas de Resultados Relatados pelo Paciente / Antidepressivos Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Revista: Psychol Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medidas de Resultados Relatados pelo Paciente / Antidepressivos Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Revista: Psychol Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM